These effects were abolished by the addition of the SIRT1 inhibitor sirtinol, indicating the critical involvement of SIRT1 in obesity-associated colon carcinogenesis [67]. Here, SIRT1 is linked to obesity due to melanocortin 4 receptor deficiency.